DAVIDSON MATT (Chief Development Officer) received a stock award from ADIAL PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 5 awards
Filed: 6/16/2026ACC: 0001213900-26-069037
DirectorOfficer· Chief Development Officer
Since Jun 2026
+531.83K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
6
Total transactions
531.83K acquired
Non-Derivative Transactions5
Common Stock
Direct
Shares
+61.65K
Price / share
—
Trade value
—
% of position
New position
6/11/2026
0.00→61.65K
Common Stock
Indirect
Shares
+3.43K
Price / share
—
Trade value
—
% of position
New position
6/11/2026
0.00→3.43K
Series A Preferred Stock
Direct
Shares
+1.82K
Price / share
—
Trade value
—
% of position
New position
6/11/2026
0.00→1.82K
Series A Preferred Stock
Indirect
Shares
+101.30
Price / share
—
Trade value
—
% of position
5.6%
6/11/2026
1.82K→1.92K
Common Stock
Direct
Shares
+232.42K
Price / share
—
Trade value
—
% of position
357.2%
6/12/2026
65.07K→297.49K
Total
Net shares
+299.41K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/11/2026 | A · Award | +61.65K | — | — | New position | 0.00 | 61.65K |
| Common Stock Indirect | 6/11/2026 | A · Award | +3.43K | — | — | New position | 0.00 | 3.43K |
| Series A Preferred Stock Direct | 6/11/2026 | A · Award | +1.82K | — | — | New position | 0.00 | 1.82K |
| Series A Preferred Stock Indirect | 6/11/2026 | A · Award | +101.30 | — | — | 5.6% | 1.82K | 1.92K |
| Common Stock Direct | 6/12/2026 | A · Award | +232.42K | — | — | 357.2% | 65.07K | 297.49K |
| Total | +299.41K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
232.42K shares
Shares
+232.42K
Strike price
2.89
Held after
232.42K
Exercisable
—
6/12/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock232.42K shares | 6/12/2026 | A · Award | +232.42K | 2.89 | — | 232.42K |